6622 Share Price Performance
HK$3.10
1.74 (127.94%)
Price HK$3.10
Share PriceHK$3.10
Is Zhaoke Ophthalmology (HKG:6622) Weighed On By Its Debt Load?
Oct 13
Zhaoke Ophthalmology Limited Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 0 Fair Values set on narratives written by author
6622 Community Narratives
There are no narratives available yet.
There are no community narratives available.
Snowflake Analysis
Zhaoke Ophthalmology Limited Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- -0.51
- 49.28%
- -787.13%
- 14.5%
About 6622
- Founded
- 2017
- Employees
- 270
- CEO
- WebsiteView website
Zhaoke Ophthalmology Limited, an ophthalmic pharmaceutical company, engages in the research, development, manufacture, and commercialization of therapies that address unmet medical needs in the People’s Republic of China, South Korea, Hong Kong, and internationally. It develops various drugs that cover ophthalmic indications, including dry eye disease, myopia, presbyopia, wet age-related macular degeneration, diabetic macular edema, and glaucoma. The company was formerly known as China Ophthalmology Focus Limited. Zhaoke Ophthalmology Limited was incorporated in 2017 and is headquartered in Guangzhou, the People’s Republic of China.
